Papuan Indigenous Model of Male Circumcision - Trial NCT06212531
Access comprehensive clinical trial information for NCT06212531 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Illinois at Chicago and is currently Completed. The study focuses on HIV Infections. Target enrollment is 239 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Illinois at Chicago
Timeline & Enrollment
N/A
Sep 07, 2020
Aug 31, 2023
Primary Outcome
Proportion of male exposed to intervention who get circumcised.
Summary
The purpose of the study is: AIM 1: To engage Papuan community members to explore
 acceptability, barriers and facilitators for introducing a school-based age and culturally
 appropriate, comprehensive VMMC intervention to reduce HIV incidence in the Papuan
 population. AIM 2: To assess the capacity of the community health system to meet
 international criteria for safe comprehensive VMMC services and to ensure the availability of
 resources and training necessary to meet these criteria in selected clinics. AIM 3: To design
 the PIM of school-based adolescent VMMC based on information collected in Aims 1 and 2 and in
 consultation with a community advisory board, the Ministry of Health and the Ministry of
 Education. AIM 4: To pilot-test the school-based PIM Intervention of VMMC with 400 boys ages
 12-18 years at two HIV high-risk Papuan locations: the Nabire and Jayapura. Primary outcomes
 are the proportion of adolescent males exposed to school-based PIM VMMC educational and
 informational sessions who get circumcised and surgical event safety. Secondary outcomes are
 satisfaction by adolescent males and parents, any sexual activity within 6 weeks after
 circumcision, changes in sexual risk behaviors between base-line and 12 weeks after
 circumcision, and perceptions of providers regarding MC training and implementation, ease of
 device use, and challenges encountered.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06212531
Non-Device Trial

